Enterotoxigenic Escherichia coli: Orchestrated host engagement

Gut Microbes

Volumn 4, Issue 5, 2013, Pages

  Fleckenstein, James M ^a,b   Munson, George M ^c   Rasko, David A ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesins; Bacterial; Enterotoxigenic Escherichia coli; Escherichia coli vaccines; Gene expression profiling; Host pathogen interaction; Transcriptome

Indexed keywords

ADHESIN; CYCLIC AMP; CYCLIC NUCLEOTIDE; ENTEROTOXIN; ESCHERICHIA COLI VACCINE; GANGLIOSIDE GM1; GUANYLATE CYCLASE; PROTEIN KINASE; PROTEINASE; TRANSCRIPTOME; VIRULENCE FACTOR;

ARTICLE; ENTEROTOXIGENIC ESCHERICHIA COLI; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; MOLECULAR EPIDEMIOLOGY; MOLECULAR PATHOLOGY; NONHUMAN;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84883419644     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gutm.25861     Document Type: Article

References (46)

1. Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect 2010; 12:89-98; PMID:19883790; http://dx.doi.org/10.1016/j.micinf.2009.10.002
2. Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol 2006; 8:1516-27; PMID:16922869; http://dx.doi.org/10.1111/j.1462-5822.2006.00736.x
3. Tauschek M, Gorrell RJ, Strugnell RA, Robins-Browne RM. Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A 2002; 99:7066-71; PMID:12011463; http://dx.doi.org/10.1073/pnas.092152899
4. Yamanaka H, Nomura T, Fujii Y, Okamoto K. Need for TolC, an Escherichia coli outer membrane protein, in the secretion of heat-stable enterotoxin I across the outer membrane. Microb Pathog 1998; 25:111-20; PMID:9790870; http://dx.doi.org/10.1006/ mpat.1998.0211
5. Foreman DT, Martinez Y, Coombs G, Torres A, Kupersztoch YM. TolC and DsbA are needed for the secretion of STB, a heat-stable enterotoxin of Escherichia coli. Mol Microbiol 1995; 18:237-45; PMID:8709843; http://dx.doi. org/10.1111/j.1365-2958.1995.mmi_18020237.x
6. Roy K, Hamilton DJ, Fleckenstein JM. Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli. Clin Vaccine Immunol 2012; 19:1603-8; PMID:22875600; http://dx.doi.org/10.1128/ CVI.00351-12
7. Fleckenstein JM, Roy K, Fischer JF, Burkitt M. Identification of a two-partner secretion locus of enterotoxigenic Escherichia coli. Infect Immun 2006; 74:2245-58; PMID:16552055; http://dx.doi. org/10.1128/IAI.74.4.2245-2258.2006
8. Roy K, Hamilton D, Allen KP, Randolph MP, Fleckenstein JM. The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection. Infect Immun 2008; 76:2106-12; PMID:18285493; http://dx.doi.org/10.1128/ IAI.01304-07
9. Roy K, Hilliard GM, Hamilton DJ, Luo J, Ostmann MM, Fleckenstein JM. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature 2009; 457:594-8; PMID:19060885; http://dx.doi.org/10.1038/nature07568
10. Patel SK, Dotson J, Allen KP, Fleckenstein JM. Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli. Infect Immun 2004; 72:1786-94; PMID:14977988; http://dx.doi.org/10.1128/ IAI.72.3.1786-1794.2004
11. Roy K, Kansal R, Bartels SR, Hamilton DJ, Shaaban S, Fleckenstein JM. Adhesin degradation accelerates delivery of heat-labile toxin by enterotoxigenic Escherichia coli. J Biol Chem 2011; 286:29771-9; PMID:21757737; http://dx.doi.org/10.1074/jbc. M111.251546
12. Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol 2009; 191:178-86; PMID:18978047; http://dx.doi.org/10.1128/JB.00822-08
13. Allen KP, Randolph MM, Fleckenstein JM. Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains. Infect Immun 2006; 74:869-75; PMID:16428729; http://dx.doi. org/10.1128/IAI.74.2.869-875.2006
14. Kansal R, Rasko DA, Sahl JW, Munson GP, Roy K, Luo Q, et al. Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions. Infect Immun 2013; 81:259-70; PMID:23115039; http://dx.doi. org/10.1128/IAI.00919-12
15. Levine MM, Ristaino P, Sack RB, Kaper JB, Orskov F, Orskov I. Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type. Infect Immun 1983; 39:889-97; PMID:6131869
16. Levine MM, Black RE, Brinton CC Jr., Clements ML, Fusco P, Hughes TP, et al. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand J Infect Dis Suppl 1982; 33:83-95; PMID:6127806
17. Bodero MD, Munson GP. Cyclic AMP receptor protein-dependent repression of heat-labile enterotoxin. Infect Immun 2009; 77:791-8; PMID:19075028; http://dx.doi.org/10.1128/IAI.00928-08
18. Espert SM, Elsinghorst EA, Munson GP. The tib adherence locus of enterotoxigenic Escherichia coli is regulated by cyclic AMP receptor protein. J Bacteriol 2011; 193:1369-76; PMID:21216994; http://dx.doi. org/10.1128/JB.00288-10
19. Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, Borst P. Characterization of the MRP4-and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 2003; 278:17664-71; PMID:12637526; http://dx.doi.org/10.1074/jbc. M212723200
20. Svennerholm AM, Lundgren A. Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Rev Vaccines 2012; 11:495-507; PMID:22551034; http://dx.doi.org/10.1586/ erv.12.12
21. Levine MM, Nalin DR, Hoover DL, Bergquist EJ, Hornick RB, Young CR. Immunity to enterotoxigenic Escherichia coli. Infect Immun 1979; 23:729-36; PMID:378834
22. Del Canto F, Botkin DJ, Valenzuela P, Popov V, Ruiz-Perez F, Nataro JP, et al. Identification of Coli Surface Antigen 23, a novel adhesin of enterotoxigenic Escherichia coli. Infect Immun 2012; 80:2791-801; PMID:22645287; http://dx.doi.org/10.1128/ IAI.00263-12
23. Peruski LF Jr., Kay BA, El-Yazeed RA, El-Etr SH, Cravioto A, Wierzba TF, et al. Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J Clin Microbiol 1999; 37:2974-8; PMID:10449484
24. Isidean SD, Riddle MS, Savarino SJ, Porter CK. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 2011; 29:6167-78; PMID:21723899; http://dx.doi. org/10.1016/j.vaccine.2011.06.084
25. Li YF, Poole S, Rasulova F, McVeigh AL, Savarino SJ, Xia D. A receptor-binding site as revealed by the crystal structure of CfaE, the colonization factor antigen I fimbrial adhesin of enterotoxigenic Escherichia coli. J Biol Chem 2007; 282:23970-80; PMID:17569668; http://dx.doi.org/10.1074/jbc.M700921200
26. Fleckenstein JM, Qadri F, Hine EE, Redman JC, Sahl JW, Sheikh AS, et al. Comparative Genome Analysis Of Enterotoxigenic E. coli Isolates From Infections Of Different Clinical Severity., 2013.
27. Turner AK, Stephens JC, Beavis JC, Greenwood J, Gewert C, Randall R, et al. Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B. Clin Vaccine Immunol 2011; 18:2128-35; PMID:21994355; http://dx.doi.org/10.1128/ CVI.05345-11
28. Darsley MJ, Chakraborty S, DeNearing B, Sack DA, Feller A, Buchwaldt C, et al. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol 2012; 19:1921-31; PMID:23035175; http://dx.doi.org/10.1128/ CVI.00364-12
29. Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 2007; 75:3961-8; PMID:17548483; http://dx.doi. org/10.1128/IAI.00459-07
30. Steinsland H, Valentiner-Branth P, Gjessing HK, Aaby P, Mølbak K, Sommerfelt H. Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study. Lancet 2003; 362:286-91; PMID:12892959; http://dx.doi.org/10.1016/S0140-6736(03)13971-2
31. Cravioto A, Reyes RE, Trujillo F, Uribe F, Navarro A, De La Roca JM, et al. Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol 1990; 131:886-904; PMID:2157338
32. Plotkin SA, Gilbert PB. Nomenclature for immune correlates of protection after vaccination. Clin Infect Dis 2012; 54:1615-7; PMID:22437237; http:// dx.doi.org/10.1093/cid/cis238
33. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/ CVI.00131-10
34. Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J, et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol 2002; 20:914-21; PMID:12172557; http://dx.doi. org/10.1038/nbt728
35. Roy K, Bartels S, Qadri F, Fleckenstein JM. Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect Immun 2010; 78:3027-35; PMID:20457787; http://dx.doi. org/10.1128/IAI.00264-10
36. Sahl JW, Steinsland H, Redman JC, Angiuoli SV, Nataro JP, Sommerfelt H, et al. A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation. Infect Immun 2011; 79:950-60; PMID:21078854; http://dx.doi.org/10.1128/ IAI.00932-10
37. Del Canto F, Valenzuela P, Cantero L, Bronstein J, Blanco JE, Blanco J, et al. Distribution of classical and nonclassical virulence genes in enterotoxigenic Escherichia coli isolates from Chilean children and tRNA gene screening for putative insertion sites for genomic islands. J Clin Microbiol 2011; 49:3198-203; PMID:21775541; http://dx.doi.org/10.1128/ JCM.02473-10
38. Rasko DA, Rosovitz MJ, Myers GS, Mongodin EF, Fricke WF, Gajer P, et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 2008; 190:6881-93; PMID:18676672; http://dx.doi. org/10.1128/JB.00619-08
39. Sahl JW, Rasko DA. Analysis of global transcriptional profiles of enterotoxigenic Escherichia coli isolate E24377A. Infect Immun 2012; 80:1232-42; PMID:22215741; http://dx.doi.org/10.1128/ IAI.06138-11
40. Mandlik A, Livny J, Robins WP, Ritchie JM, Mekalanos JJ, Waldor MK. RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expression. Cell Host Microbe 2011; 10:165-74; PMID:21843873; http://dx.doi.org/10.1016/j. chom.2011.07.007
41. Croucher NJ, Thomson NR. Studying bacterial transcriptomes using RNA-seq. Curr Opin Microbiol 2010; 13:619-24; PMID:20888288; http://dx.doi. org/10.1016/j.mib.2010.09.009
42. Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, Mu Y, et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 2005; 102:547-52; PMID:15647345; http://dx.doi.org/10.1073/ pnas.0408782102
43. Roy K, Hamilton D, Ostmann MM, Fleckenstein JM. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model. Vaccine 2009; 27:4601-8; PMID:19523914; http://dx.doi. org/10.1016/j.vaccine.2009.05.076
44. Roy K, Hamilton DJ, Munson GP, Fleckenstein JM. Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli. Clin Vaccine Immunol 2011; 18:1803-8; PMID:21900530; http:// dx.doi.org/10.1128/CVI.05217-11
45. Freedman DJ, Tacket CO, Delehanty A, Maneval DR, Nataro J, Crabb JH. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis 1998; 177:662-7; PMID:9498445; http://dx.doi. org/10.1086/514227
46. Evans DG, Graham DY, Evans DJ Jr. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. Gastroenterology 1984; 87:934-40; PMID:6381216